Join Clinilabs on Tuesday, May 10th at 12pm ET, for our next webinar series titled, “Testing a New Paradigm of Parkinson’s Disease and Transforming the Clinical Experience”. Our guest speaker, Dr. Jonathan Sackner-Bernstein, is a widely sought expert in medical product development, with expertise from first-in-human to post-market stages with deep understanding of regulatory, clinical, operational, analytic, and due-diligence processes. Recently, Dr. Bernstein has identified a novel candidate drug therapy for Parkinson’s disease (patent pending), along with working through regulatory steps required to start a clinical trial.

During this webinar, Dr. Bernstein will:

• Define a new paradigm for Parkinson’s disease
• Identify therapeutic implications of this discovery
• Delineate a path to test this new paradigm, and in parallel, the possibility of modifying the disease

Register today to learn more on this great topic!